11/20
11:36 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.
11/20
11:36 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at William Blair.
10/24
08:08 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
High
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
10/9
10:52 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
9/25
02:04 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $138.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $138.00 price target on the stock.
9/25
01:49 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
9/25
01:49 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
9/12
08:55 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.
9/12
08:55 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.
9/12
08:10 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
9/12
08:10 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
9/11
08:16 am
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
9/11
08:02 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $80.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $80.00 price target on the stock.